Hereditary sensory neuropathies (HSNs) are rare disorders characterized by progressive
|
|
- Hester York
- 6 years ago
- Views:
Transcription
1 SECTION EDITOR: DAVID E. PLEASURE, MD Autosomal Dominant Inherited Neuropathies With Prominent Sensory Loss and Mutilations A Review NEUROLOGICAL REVIEW Michaela Auer-Grumbach, MD; Peter De Jonghe, MD, PhD; Kristien Verhoeven, PhD; Vincent Timmerman, PhD; Klaus Wagner, PhD; Hans-Peter Hartung, MD; Garth A. Nicholson, MD, PhD Hereditary sensory neuropathies (HSNs) are rare disorders characterized by progressive distal sensory loss, predominantly affecting the lower limbs. Foot ulcers, severe skin and bone infections, arthropathy, and amputations are frequent and feared complications. Occasionally, patients complain of spontaneous shooting or lancinating pain. Autonomic fibers can be affected to a variable degree. Patients with HSN can also have severe distal weakness, and some HSN variants have therefore been classified among the hereditary motor and sensory neuropathies (HMSNs). Molecular genetic studies of autosomal dominant inherited neuropathies with prominent sensory loss and ulceromutilating features have assigned the genetic loci for HMSN type 2B (Charcot-Marie-Tooth syndrome type 2B) and HSN type 1 to chromosomes 3q13-22 and 9q , respectively. However, some families with HSN have been excluded for linkage to these loci, suggesting further genetic heterogeneity. Recently, disease-causing mutations in the SPTLC1 gene have been identified in patients with HSN type 1. In this review, we discuss the hallmark features associated with the distinct genetic subtypes of autosomal dominant inherited HSN and provide genotype-phenotype correlations. Arch Neurol. 2003;60: Inherited neuropathies are a clinically and genetically heterogeneous group of disorders of the peripheral nervous system. They are subdivided into 3 main categories based on the predominant involvement of motor and/or sensory nerves. In the most common variants, the hereditary motor and sensory neuropathies (HMSNs), both motor and sensory nerves are clearly affected, 1 and the associated phenotype is classic Charcot-Marie- Tooth syndrome (CMT). Distal hereditary motor neuropathies (distal HMN, spinal CMT, and distal spinal muscular atrophy) 2 caused by an exclusive degeneration of motor nerve fibers are much rarer. Finally, neuronal degeneration, From the Institute of Medical Biology and Human Genetics, Karl-Franzens University Graz, Graz, Austria (Drs Auer-Grumbach and Wagner); the Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, University of Antwerp (Drs De Jonghe, Verhoeven, and Timmerman), and the Division of Neurology, University Hospital Antwerp (Dr De Jonghe), Antwerp, Belgium; the Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany (Dr Hartung); and the Neurobiology Laboratory, Anzac Research Institute, University of Sydney, Concord Hospital, Concord, Australia (Dr Nicholson). mainly affecting the peripheral sensory nerves and sometimes involving the autonomic nerves, results in hereditary sensory neuropathy (HSN) or hereditary sensory and autonomic neuropathy (HSAN), respectively. 3 However, marked interfamilial and intrafamilial variability of clinical, electrophysiological, and morphological features may hamper a correct classification of individual cases. Recent molecular genetic studies have significantly advanced our understanding of these disorders and have resulted in a more rational classification of inherited peripheral neuropathies. 4-6 In this review, we focus on autosomal dominant inherited peripheral neuropathies that show striking sensory loss and are often complicated by severe infections and amputations. Based on the literature and our experiences, we provide detailed descriptions of the currently known genetic subtypes and corresponding phenotypes. The challenge of a rational classification of these disorders is discussed. 329
2 HISTORICAL NOTES The first description of familial neurotrophic plantar ulcers can be traced to a report by Nelaton in Subsequently, additional kinships were reported. Most early descriptive diagnoses referred to the ulcers as the most striking feature of the disease or speculated about the underlying disease mechanism. Thus, historically, the disorders were named hereditary perforating ulcers, 8 familial trophoneurosis, 9 familial syringomyelia, 10 hereditary sensory radicular neuropathy, 11,12 or ulcerative and mutilating acropathy, 13 among others. In the dermatological literature, the term Thevenard syndrome 14 is still used for familial forms, whereas isolated cases of neuropathic ulcerations of unknown origin are classified as Bureau-Barrière syndrome. 15 CURRENT CLASSIFICATION In 1975, Otha and Dyck 16 proposed a descriptive classification of the inherited peripheral neuropathies and thereby introduced the term HSN. Dyck updated this classification in The autosomal dominant variant and most common subtype is HSN type 1 (HSN1). 3 Based on the presence of additional features, Dyck further subdivided HSN1 in These additional features were then thought to result from the expression of different genes, different alleles of a single gene, modifying genes, or environmental factors. In the presence of autonomic features, the disorder was named HSAN. 3 Donaghy et al 17 suggested another classification based on the mode of inheritance, but the term HSN is still more commonly used. 18 The presence of severe motor deficits in some kinships was described long ago 11-13,19 and has been a source of confusion because it blurs the boundaries between HMSN and HSN. 20 PHENOTYPIC CHARACTERISTICS Clinical Symptoms The disorder usually starts within the second to third decade of life but may occasionally have a later onset. The first signs are often foot deformity and sensory loss. Pes cavus, pes planus, and/or hammertoes may be present since childhood. Badly fitting shoes promote the early occurrence of callus, particularly at the convexity of curled toes or other pressure points. 3 Skin changes, such as recurrent paronychia and onychomycosis, are early and frequent findings. Often, patients do not notice sensory loss for a long time. However, some patients may complain of loss of pain and temperature sensation 12 or may have loss of all sensory modalities at the onset of the disease. 13,21-23 In the early stages of the disease, sensory abnormalities are often limited to the toes, but they then spread to the distal parts of the lower limbs, occasionally extending up to the knees. Many patients only become aware of the disease when they notice painless injuries and burns or when they seek medical advice for slowly healing foot ulcers. Once infections occur, complications such as osteomyelitis and osteonecrosis may follow. 3,21 These may sometimes lead to shortening of the feet due to bone loss and can necessitate amputations of the toes or even parts of a limb at more proximal sites. Pain is frequently reported and is usually related to local events but can also occur spontaneously. 3 In some kinships, this spontaneous pain has a lancinating or shooting character and often occurs in the feet, legs, thighs, hands, and even shoulders. 8,11,12 Occasionally, spontaneous pain is the most prominent sign of the disease. Progressive hearing loss or even complete deafness may occur. 3 In addition, many patients exhibit, to a variable degree, symmetrical distal muscle wasting and weakness, resulting in severe gait disturbances. 11,13,19,21-24 Weakness may occasionally be an initial sign of the disorder. As the disease progresses, hands can show distal sensory loss and muscle wasting, 6,22,24 and, in severe cases, neuropathic arthropathy can develop. 3 Disturbed sweating (hypohidrosis, hyperhidrosis, or anhidrosis) is the most frequent manifestation of autonomic nervous system dysfunction, 3 whereas hypotension, erectile dysfunction, and disturbed lacrimation are rare. Progression is usually slow, but, occasionally, patients may have severe proximal limb weakness and require a wheelchair. 3 As in most other autosomal dominant disorders, the severity of the disease can be extremely variable, even within one family. Whether burning feet syndrome represents a very mild variant of HSN remains elusive at present. 25 Clinical Neurological Findings The clinical findings of HSN consist of changes in sensation, muscle strength, reflexes, and autonomic function. All sensory modalities can be affected, but sometimes loss of pain and thermal sense is striking, suggesting a predominant small-fiber neuropathy. However, complete loss of touch-pressure sense occurred while joint position sense was affected in some kindreds. 3 Interestingly, vibration sense can be preserved for a long time, even when other sensory modalities are already severely abnormal (personal observation, M.A.-G., 1999). Peroneal muscles may be preferentially wasted and weak. 11,13,19,22-24 Patellar tendon reflexes are often preserved or even brisk but disappear with progression of the disease, 3,21 whereas Achilles tendon reflexes are usually diminished or absent. Pyramidal tract signs are not a common feature, although spasticity of the lower limbs has been reported in a form of HSN with spastic paraplegia. 26 Neurophysiological Findings Most patients with HSNs have an axonal neuropathy. 3 Changes in nerve conduction studies are generally more severe in lower than in upper limbs. Sensory nerves are primarily affected and sural nerve responses may be absent. Compound motor action potential amplitudes are reduced, and motor nerve conduction velocities (NCVs) are slightly slowed. With complete denervation of the distal muscles, compound motor action potentials may not be recordable. In some kinships, severe dispersion of compound motor action potentials and moderate slowing of motor NCVs suggested an additional underlying demyelinative process that has also been demonstrated in studies of nerve biopsy specimens. 21,23 In a large family with CMT type 2B (CMT2B), it has been shown that it is rarely possible to identify mutation carriers at the preclinical 330
3 stage by NCV studies. 23 Electromyography shows chronic neurogenic alterations, sometimes with spontaneous activity such as fibrillations, sharp waves, and complex repetitive discharges. Pathological Findings Jughenn et al 27 were the first to determine that syringomyelia does not occur in patients with HSN1. Unequivocal abnormalities in the peripheral nerves in a postmortem study included the absence of almost all myelinated fibers, an increased number of Schwann cell nuclei, thickened perineuria, and a discontinuity of myelin. Subsequently, Denny-Brown 11 described a decrease of dorsal root ganglion cells and the loss of fibers in the dorsal root entry zone and the posterior columns. All these findings suggested that degeneration of the dorsal root ganglia cells was the primary pathological event in HSN. Studies by Dyck et al 3,28 focused on the pathological alterations of the sural nerve and clearly demonstrated that fibers of all size classes are affected. However, small fibers may be preferentially involved compared with large fibers. In addition, fibers appeared to undergo atrophy, myelin wrinkling, demyelination, and remyelination as well as axonal degeneration. MOLECULAR GENETICS Charcot-Marie-Tooth Syndrome Type 2B and Hereditary Motor and Sensory Neuropathy Type 2B In 1995, Kwon et al 6 described a single large kinship in which 10 family members were affected by a neuropathy with prominent distal sensory loss. Six patients reported recurrent foot ulcers, and 4 had amputations of the toes because of recurrent infections. In addition, all affected individuals had prominent symmetrical distal motor weakness and wasting. 6,24 Thus, the disorder in this family was not classified as HSN1 but instead was grouped among the axonal forms of HMSN (CMT) and genetically categorized as CMT2B (Online Mendelian Inheritance in Man [OMIM] entry ; available at This classification has been questioned. 20 The gene locus was mapped to a 30 centimorgan (cm) interval on chromosome 3q13-q22. 6 So far, 2 other families, 1 Scottish and 1 Austrian, have been identified and the genetic interval was reduced to a region of 10 cm. 22,23 In both families, a distinct clinical CMT2B pattern was documented, consisting of prominent motor and sensory disturbances with ulceromutilating complications. In the 3 CMT2B families described, no patients complained of lancinating pain, and sensory loss equally affected all modalities. Studies of NCV showed axonal degeneration, and demyelination was observed with progression of the disease. Recently, Verhoeven et al 29 reported that 2 missense mutations in the small GTP-ase late endosomal protein RAB7 cause CMT2B. Hereditary Sensory Neuropathy Type 1 In 1996, Nicholson et al 5 reported 1 large and 3 small Australian kinships with HSN1 (OMIM entry ) and mapped the gene locus to an 8-cM region on chromosome 9q22. Linkage of HSN1 to chromosome 9q was confirmed in a large American family of German origin, and the HSN1 locus was further refined. 30 Recently, 3 different missense mutations (C133Y, C133W, and V144D) in the SPTLC1 gene (OMIM entry ) encoding serine palmitoyltransferase long-chain base subunit 1 have been identified in 11 families with HSN1 from Australia, England, and Austria. 31 Interestingly, haplotype analysis of 3 Australian families of English origin and 3 English families with the same SPTLC1 mutation (C133W) demonstrated that these families had a common founder. 32 Serine palmitoyltransferase is a pyridoxal 5 phosphate dependent enzyme that consists of 2 subunits, serine palmitoyltransferase long-chain base subunits 1 and 2. Serine palmitoyltransferase catalyzes the first step of sphingolipid biosynthesis, including ceramide and sphingomyelin. Both subunits are required for enzyme activity. Recent studies suggest that ceramide functions as a bioactive lipid, modulating several biochemical and cellular responses to stress, including apoptosis, cell-cycle arrest, and cell senescence. Ceramide produced by sphingomyelin catabolism is known to mediate programmed cell death, and increased de novo ceramide synthesis causes apoptosis during early neural differentiation in vitro. 31 Measuring the rate of de novo synthesis of ceramide and a ceramide metabolite, glycosyl ceramide, in intact cells has demonstrated that HSN1 patients with SPTLC1 mutations have similar serine palmitoyltransferase activity to that in lymphoblast cell lines from healthy controls. Thus, it has been suggested that HSN1 is not caused by haploinsufficiency (decrease of normal function), but neuronal degeneration in HSN1 may be caused by an increase in serine palmitoyltransferase enzyme activity that leads, in neurons, to increased de novo ceramide synthesis and apoptosis. 31 Alternatively, the mutant enzyme subunit protein may gain a toxic function. Clinical features common to all chromosome 9q linked families with HSN1 have been found. The clinical phenotype of the large Australian kinship has been originally described as hereditary sensory radicular neuropathy. 12 In the Austrian family with the C133Y missense mutation, the 6 affected individuals (4 living and 2 deceased) had prominent sensory loss with a predilection for pain and thermal sense, whereas vibration sense was preserved for a long time. Sensory disturbance was the initial sign in 5 family members who became aware of the disease as they developed painless injuries or burns. Five older patients reported attacks of shooting and lancinating pain that was difficult to control. Four family members had recurrent foot ulcerations, all of them resulting in osteonecrosis and osteolysis and subsequently necessitating amputations of bones, toes, or even legs. Pes cavus was observed in 1 patient. Three individuals reported autonomic features, consisting of hyperhidrosis. Two older patients developed hearing loss. In addition, most of our patients with HSN1 had prominent distal muscle weakness and wasting in both lower and upper limbs. This was the presenting sign in the 331
4 Table 1. Key Features in Different Types of Autosomal Dominant Inherited Neuropathies With Ulceromutilating Complications Feature HSN Type 1 CMT Type 2B Unlinked Types CMT Type 1 Sensory loss and qualities affected Motor deficit Spontaneous pain Nerve conduction velocities Severe, frequently predominant loss of pain and temperature sensation; vibration sense may be preserved Variable, mild to prominent; hand muscles may also be severely wasted Often a prominent feature; shooting or lancinating character; may be widespread Axonal neuropathy Mild to severe; all modalities equally affected Often first and most prominent sign of the disease; hand muscles mildly affected; pes cavus Mild to severe; all modalities equally affected Mild to severe; hand muscles rarely affected; pes cavus Mild to severe; all modalities equally affected Mild to severe; hand muscles often also severely wasted; pes cavus Absent Usually absent Absent or present; burning character or cramps; usually affecting the legs only Axonal (and demyelinating) neuropathy; may enable preclinical diagnosis Abbreviations: CMT, Charcot-Marie-Tooth syndrome; HSN, hereditary sensory neuropathy. Axonal (and demyelinating) neuropathy Demyelinating neuropathy youngest patient, who received the diagnosis of HMSN2. Studies of NCV suggested an axonal neuropathy, but compound motor action potentials and sensory nerve action potentials were often not recordable. We have personally examined several families with CMT2B and HSN1. We found that the presence of shooting and lancinating pain is an important clinical hallmark of HSN1. Another characteristic feature of HSN1 is severe loss of pain and temperature sensation, leading to painless injuries. The degree of muscle involvement clearly fails to distinguish these 2 subtypes because it can be severe in both forms. Hereditary Sensory Neuropathy Not Linked to Chromosomes 3q13-22 and 9q In 2 families from Austria 21 and Italy, 33 linkage to the CMT2B and HSN1 loci was excluded. In the Austrian family, 9 individuals were definitively affected. Both motor and sensory signs were less pronounced, whereas foot deformity, skin changes, and ulceromutilating features were a prominent and frequent finding. All sensory modalities were equally affected. None of the patients complained of spontaneous pain, in contrast to the Italian family. The results of NCV studies were normal or slightly to moderately slowed. Ulceromutilating Features in Other Inherited Neuropathies Other types of inherited neuropathies, in particular HMSN1 (CMT1), may have some features in common with autosomal dominant HSN. We found 5 families with a severe demyelinating neuropathy and prominent sensory loss in which several affected family members had pronounced foot deformity, causing multiple pressure points and leading to the development of foot ulcers. Molecular genetic studies in these families revealed that the CMT1A duplication on chromosome 17p11.2 was the underlying genetic defect. One of these families had been diagnosed with HSN1 in 1977 based on the presence of severe sensory loss and recurrent ulceromutilating complications in affected individuals. 34 Similar observations have been reported in 2 families with CMT1A from England. 35 MANAGEMENT At present, no specific treatment is available for inherited neuropathies with prominent sensory loss and ulceromutilating features. The main goal is the prevention of foot complications. Patients must be carefully instructed about the risk of developing foot ulcers and infections. Unnoticed sensory loss, which can lead to painless injuries and burns, must be detected by careful neurological assessment. Patients should wear comfortable shoes, and pressure points caused by foot deformity can be avoided with orthopedic shoes. Furthermore, the shoes should be carefully inspected for foreign bodies before being worn. Long walks should be avoided, and daily inspection of the feet is necessary to recognize fissures or other skin changes. Good regular care of the feet is indispensable. If an ulcer or infection occurs nevertheless, it must be treated adequately and immediately. Weight bearing should then be discontinued. The ulcer should be cleaned, and treatment with antibiotics might become necessary. Radiography should be performed early to exclude an underlying osteomyelitis. Genetic counseling is required before testing preclinical cases. At-risk individuals should be informed about their 50% risk of having inherited the disease gene from an affected parent. Molecular genetic testing is needed to confirm the diagnosis. Known CMT1 mutations should be excluded first in patients with demyelinating neuropathy. Axonal neuropathies can be screened for mutations within the SPTLC1 gene. Also, patients with the phenotype of CMT2B can now be tested for mutations in the RAB7 gene. CONCLUSIONS Genetic heterogeneity has been shown in autosomal dominant inherited peripheral neuropathies with predominant sensory loss and ulceromutilating features. How- 332
5 Table 2. Differential Diagnosis of Sporadic Cases of Ulceromutilating Neuropathies or Foot Ulcers Diabetes mellitus Neurotoxins (eg, alcohol, chemotherapeutic agents, gold, isoniazid, hydralazine) Amyloidosis Syringomyelia Other spinal cord disorders Tabes dorsalis Leprosy Arteriosclerosis* Venous ulcer* Progeria adultorum (Werner syndrome)* Artifacts* Carcinoma cuniculatum* Acral-lentiginous amelanotic melanoma* *In cases that are also complicated by neuropathy. ever, no satisfying nomenclature of these disorders is available at present. Both HMSN1 (CMT1) and HMSN2 (CMT2) can be complicated by ulceromutilations, whereas patients with HSN1, although usually characterized by severe sensory loss, ulcers, and amputations, may also present with prominent motor involvement and no ulcers. 11,13,19 The situation is also complicated by intrafamilial phenotypic variability. Therefore, classification of these disorders can no longer be based on the type of affected nerve fibers. Classification of the first CMT2B family, 6 described as an axonal type of HMSN (CMT), was criticized. 20 However, recently it has been suggested to classify HSN1 as a form of HMSN2 (CMT2) 4,36 because motor deficits are often present. In this novel classification, CMT2B accounts for CMT2 with prominent sensory deficits. 4 A classification according to the most prominent clinical feature, ie, the ulceromutilations, as has been used in the past, still makes sense. It highlights the most prominent clinical characteristics of the disease, but it fails in those patients within a family who do not have ulceromutilating complications. Molecular genetic linkage studies in more families are needed to confirm or identify new genes and to document phenotypic variation. Such studies require a very careful ascertainment of at-risk family members. 37 Table 1 provides key signs and symptoms of the different types of these diseases that should be assessed. Table 2 gives an overview of the most important differential diagnoses in sporadic cases. The identification of additional genes involved in these disorders and of the underlying abnormalities will lead to a more satisfying nomenclature. Accepted for publication February 27, Author contributions: Study concept and design (Drs Auer-Grumbach, De Jonghe, Timmerman, and Wagner); acquisition of data (Dr Auer-Grumbach); analysis and interpretation of data (Drs Auer-Grumbach, Verhoeven, Hartung, and Nicholson); drafting of the manuscript (Drs Auer-Grumbach, De Jonghe, Timmerman, and Wagner); critical revision of the manuscript for important intellectual content (Drs Auer-Grumbach, Verhoeven, Hartung, and Nicholson). This study was supported by grants FWF P BIO and FWF P15378 from the Fonds zur Förderung der wissenschaftlichen Forschung, Vienna, Austria. Drs Verhoeven and Timmerman are postdoctoral fellows of the Fund for Scientific Research, Flanders, Belgium. Corresponding author: Michaela Auer-Grumbach, MD, Institute of Medical Biology and Human Genetics, Karl- Franzens University Graz, Harrachgasse 21/8, A-8010 Graz, Austria ( michaela.auergrumbach@kfunigraz.ac.at). REFERENCES 1. Dyck PJ, Chance P, Lebo R, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1993: Harding AE. Inherited neuronal atrophy and degeneration, predominantly of lower motor neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders Co; 1993: Dyck PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders Co; 1993: Vance JM. The many faces of Charcot-Marie-Tooth disease. Arch Neurol. 2000; 57: Nicholson GA, Dawkins JL, Blair IP, et al. The gene for hereditary sensory neuropathy type I (HSN-I) maps to chromosome 9q22.1-q22.3. Nat Genet. 1996; 13: Kwon JM, Elliott JL, Yee WC, et al. Assignment of a second Charcot-Marie- Tooth type II locus to chromosome 3q. Am J Hum Genet. 1995;57: Nelaton M. Affection singulière des os du pied. Gaz Hop Civils Militaires. 1852; 4: Hicks EP. Hereditary perforating ulcer of the foot. Lancet. 1922;1: Beiglböck W. Zum Erbgang der Trophoneurose. Wien Klin Wochenschr. 1938; 48: Van Epps C, Kerr HD. Familial lumbosacral syringomyelia. Radiology. 1940;35: Denny-Brown D. Hereditary sensory radicular neuropathy. J Neurol Neurosurg Psychiatr. 1951;14: Wallace DC. Hereditary sensory radicular neuropathy: a family study. In: Archdall Medical Monograph No. 8. Sydney: Australian Medical Pub Co Ltd; 1970: Partsch H. Hereditäre sensorische Neuropathie (Denny-Brown) (familiäre Akroosteolyse). Wien Klin Wochenschr. 1970;82: Thevenard A. L acropathie ulcéro-mutilante familiale. Rev Neurol (Paris). 1942; 74: Bureau Y, Barrière H. Acropathies ulcéro-mutilantes pseudo-syringomyeliques non familiales des membres inferieurs. Arch Belg Dermatol Syphiligr. 1958;14: Dyck PJ. Inherited neuronal degeneration and atrophy affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Philadelphia, Pa: WB Saunders Co; 1975: Donaghy M, Hakin RN, Bamford JM, et al. Hereditary sensory neuropathy with neurotrophic keratitis. Brain. 1987;110: Thomas PK. Hereditary sensory neuropathies. Brain Pathol. 1993;3: Dyck PJ, Kennel AJ, Magal IV, Kraybill EN. A Virginia kinship with hereditary sensory neuropathy, peroneal muscular atrophy, and pes cavus. Mayo Clin Proc. 1965;40: Vance JM, Speer MC, Stajich JM, et al. Misclassification and linkage of hereditary sensory and autonomic neuropathy type I as Charcot-Marie-Tooth disease type 2B. Am J Hum Genet. 1996;59: Auer-Grumbach M, Wagner K, Timmerman V, De Jonghe P, Hartung HP. Ulceromutilating neuropathy in an Austrian kinship without linkage to hereditary motor and sensory neuropathy IIB and hereditary sensory neuropathy I loci. Neurology. 2000;54: De Jonghe P, Timmerman V, FitzPatrick D, Spoelders P, Martin JJ, Van Broeckhoven C. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry. 1997; 62:
6 23. Auer-Grumbach M, De Jonghe P, Wagner K, Verhoeven K, Hartung HP, Timmerman V. Phenotype-genotype correlations in a CMT2B family with refined 3q13- q22 locus. Neurology. 2000;55: Elliott JL, Kwon JM, Goodfellow PJ, Yee WC.Hereditary motor and sensory neuropathy IIB: clinical and electrodiagnostic characteristics. Neurology. 1997;48: Stögbauer F, Young P, Kuhlenbaumer G, et al. Autosomal dominant burning feet syndrome. J Neurol Neurosurg Psychiatry. 1999;67: Cavanagh NP, Eames RA, Galvin RJ, Brett EM, Kelly RE. Hereditary sensory neuropathy with spastic paraplegia. Brain. 1979;102: Jughenn H, Krücke W, Wadulla H. Zur Frage der familiären Syringomyelie (klinischanatomische Untersuchungen über familiäre neuro-vasculäre Dystrophie der Extremitäten ). Arch Psychiatr Neurol. 1949;182: Lambert EH, Dyck PJ. Compound action potentials of sural nerve in vitro in peripheral neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Philadelphia, Pa: WB Saunders Co; 1975: Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet. In press. 30. Bejaoui K, McKenna-Yasek D, Hosler BA, et al. Confirmation of linkage of type 1 hereditary sensory neuropathy to human chromosome 9q22. Neurology. 1999; 52: Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001;27: Nicholson GA, Dawkins JL, Blair IP, Auer-Grumbach M, Brahmbhatt SB, Hulme DJ. Hereditary sensory neuropathy type I: haplotype analysis shows founders in southern England and Europe. Am J Hum Genet. 2001;69: Bellone E, Rodolico C, Toscano E, et al. A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT 2B) or hereditary sensory neuropathy type I (HSN I) loci. Neuromuscul Disord. 2002;12: Balasz S, Gebhart W, Lassmann G, Partsch H, Sluga EE, Vass K. Familiäre Form einer kombinierten sensorischen Neuropathie. In: Lassmann G, Jurecka W, Niebauer G. Verlag des Verbandes der Wissenschaftlichen Gesellschaften, Wien, Wiener Symposium: Struktur und Pathologie des Hautnervensystems. Vienna, Austria; 1977: Thomas PK, Marques WJ, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain. 1997;120: Nicholson GA, Blair IP, Dawkins J, Brahmbhatt S, Hulme D. Hereditary sensory neuropathy type I (HSNI): haplotype analysis and classification as a neural form of Charcot-Marie-Tooth neuropathy (CMT2) [abstract]. J Peripher Nerv Syst. 1999; 4: Dyck PJ, Dyck JB, Schaid DJ. Genetic heterogeneity in hereditary sensory and autonomic neuropathies: the need for improved ascertainment. Muscle Nerve. 2000;23: Call for Papers T he Archives of Neurology will be publishing a theme issue on pain management for our November 2003 issue in association with a complementary publication by JAMA. We invite and encourage submissions of reviews, original contributions, and case reports on clinical and basic neuroscience issues related to pain mechanisms, clinical syndromes, and pain therapeutics. All submissions must be received by May 1, 2003, to be considered. Roger Rosenberg, MD, Editor 334
Three patients in a Chinese family with hereditary sensory neuropathy mimicking leprosy
Lepr Rev (2008) 79, 441 446 CASE REPORT Three patients in a Chinese family with hereditary sensory neuropathy mimicking leprosy JIANPING SHEN*, GUOCHENG ZHANG*, RONGDE YANG**, TINGYING HU** & MIN ZHOU*
More informationA family study of Charcot-Marie-Tooth disease
Joturnal of Medical Genetics, 1982, 19, 88-93 A family study of Charcot-Marie-Tooth disease A P BROOKS* AND A E H EMERY From the University Department of Human Genetics, Western General Hospital, Edinburgh
More informationCharcot-Marie-Tooth Disease (CMT) Sometimes known as Hereditary Motor and Sensory neuropathy (HMSN) or Peroneal Muscular Atrophy (PMA)
Version: 2 Published: January 2004 Updated: December 2009 Date of review: November 2011 Author: Dr.Hilton-Jones MD, FRCP, FRCPE Clinical Director, Oxford MDC Muscle and Nerve Centre, and revised by Dr.
More informationClinical And Genetic Study of The Sptlc1 Gene Mutation in Patients With Heridetary Sensory Neuropahty Type 1
Clinical And Genetic Study of The Sptlc1 Gene Mutation in Patients With Heridetary Sensory Neuropahty Type 1 Mourad H a, Fadel W b and El Batch M c a Department of Clinical Pathology, b Department of Neurology
More informationA Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017
A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017 Disclosures Research support from Cytokinetics, Inc Catalyst, Inc Editorial fees from UptoDate. Objectives Describe
More informationDistal chronic spinal muscular atrophy involving the hands
Journal ofneurology, Neurosurgery, and Psychiatry, 1978, 41, 653-658 Distal chronic spinal muscular atrophy involving the hands D. J. O'SULLIVAN AND J. G. McLEOD From St Vincent's Hospital, and Department
More informationTable of Contents. 1 Architecture of the peripheral nerve P. Young, M. Boentert
Table of Contents z General part 1 Architecture of the peripheral nerve... 3 P. Young, M. Boentert Introduction... 3 1.1 Cellular components of the PNS... 3 1.2 Architecture of the myelin compartment..
More informationGuide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists
Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists What is NCS/EMG? NCS examines the conduction properties of sensory and motor peripheral nerves. For both
More informationDSS-1. No financial disclosures
DSS-1 No financial disclosures Clinical History 9 year old boy with past medical history significant for cerebral palsy, in-turning right foot, left clubfoot that was surgically corrected at 3 years of
More informationStage I: Rule-Out Dashboard Secondary Findings in Adults
Stage I: Rule-Out Dashboard GENE/GENE PANEL: DNM2 DISORDER: DNM2-Related Intermediate Charcot-Marie-Tooth Neuropathy HGNC ID: 2974 OMIM ID: 606482 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource,
More informationCharcot-Marie-Tooth disease (CMT) is the eponym
ORIGINAL ARTICLE Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies Anita S.D. Saporta, MD, 1 Stephanie L. Sottile, BA, 1 Lindsey J. Miller, MS, 1 Shawna M.E. Feely, MS, 1 Carly E. Siskind,
More informationPeripheral Neuropathy
Peripheral Neuropathy Neuropathy affects 30-50% of patient population with diabetes and this prevalence tends to increase proportionally with duration of diabetes and dependant on control. Often presents
More informationAII-type: Select the most appropriate answer
AII-type: Select the most appropriate answer ( )1. Choose one best answer for the following pathologic pictures. A. choroid cyst B. choroid papilloma C. pontine glioma D. ependymoma E. metastatic tumor
More informationNovember 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by
November 16-18, 2017 Hotel Monteleone New Orleans, LA Provided by Diabetic Neuropathy: A Global and Growing Problem John D. England, MD Louisiana State University Health Sciences Center School of Medicine
More informationComparison of Sudomotor and Sensory Nerve Testing in Painful Sensory Neuropathies
138 Original Article Comparison of Sudomotor and Sensory Nerve Testing in Painful Sensory Neuropathies James M. Killian, MD,* Shane Smyth, MD,* Rudy Guerra, PhD, Ishan Adhikari, MD,* and Yadollah Harati,
More information419 Church Street East, Penrose, Auckland 1642 P O Box 12063, Penrose, Auckland
CHARCOT-MARIE-TOOTH DISEASE What is Charcot-Marie-Tooth Disease? First described in 1886 by three physicians Jean-Marie Charcot, Pierre Marie, and Howard Henry Tooth, CharcotMarie-Tooth (CMT) is a group
More informationMR Imaging of the Cauda Equina in Charcot-Marie-Tooth disease
MR Imaging of the Cauda Equina in Charcot-Marie-Tooth disease Poster No.: C-0741 Congress: ECR 2015 Type: Scientific Exhibit Authors: Y. Tatewaki, S. Nishiyama, Y. Kato, T. Murata, S. Mugikura, L. Li,
More informationThe Internist s Approach to Neuropathy
The Internist s Approach to Neuropathy VOLKAN GRANIT, MD, MSC ASSISTANT PROFESSOR OF NEUROLOGY NEUROMUSCU LAR DIVISION UNIVERSITY OF MIAMI, MILLER SCHOOL OF MEDICINE RELEVANT DECLARATIONS Financial disclosures:
More informationGENETICS IN HEREDITARY NEUROPATHY
GENETICS IN HEREDITARY NEUROPATHY ERNESTO ALONSO, SWETHA JASTI,MAZEN M.DIMACHKIE, RICHARD J. BAROHN, MELANIE GLENN, OMAR JAWDAT, JEFFREY STATLAND, LAURA HERBELIN, CONSTANTINE FARMAKIDIS,DUAA JABARI, MAMATHA
More informationA CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL
A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL CASE HISTORY Nine year old male child Second born Born
More informationFacts about Charcot-Marie-Tooth Disease
The information in this fact sheet was adapted by the MDANSW (01/07) from the MDA USA fact sheet (updated 11/06) with their kind permission. Facts about Charcot-Marie-Tooth Disease What is Charcot-Marie-Tooth
More informationCIDP + MMN - how to diagnose and treat. Dr Hadi Manji
CIDP + MMN - how to diagnose and treat Dr Hadi Manji Outline Introduction CIDP Diagnosis Clinical features MRI Nerve conduction tests Lumbar puncture Nerve biopsy Treatment IV Ig Steroids Plasma Exchnage
More informationGenetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report
Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences
More informationTest Information Sheet
Genetic Testing for Neuropathy: Axonal Charcot-Marie-Tooth Panel Sequencing and Exon-Level Deletion/Duplication Testing of 21 Genes Panel Gene List: AARS, BSCL2, DNM2, DYNC1H1, GARS, GDAP1, GJB1, HINT1,
More informationAbstract. Introduction
Brazilian Journal of Medical and Biological Research (2003) 36: 1403-1407 Thr(118)Met in Charcot-Marie-Tooth disease ISSN 0100-879X 1403 Thr(118)Met amino acid substitution in the peripheral myelin protein
More information1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we?
Neuromuscular Disease: Muscular Dystrophy Muscular Dystrophy Association (MDA) and OSF HealthCare Illinois Neurological Institute (INI) Care Center Team The Neuromuscular clinic is a designated MDA Care
More informationThe near-nerve sensory nerve conduction in tarsal tunnel syndrome
Journal of Neurology, Neurosurgery, and Psychiatry 1985;48: 999-1003 The near-nerve sensory nerve conduction in tarsal tunnel syndrome SHN J OH, HYUN S KM, BASHRUDDN K AHMAD From the Department ofneurology,
More informationinitially believed to be a distinct syndrome. However,
JMed Genet 1991; 28: 1-5 Review article Hereditary motor and sensory neuropathies Jeffery M Vance The hereditary motor and sensory neuropathies (HMSN) represent a genetically heterogeneous collection of
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_the_diagnosis_of_inherited_peripheral_neuropathy
More informationDiabetic Foot Ulcers. Alex Khan APRN ACNS-BC MSN CWCN CFCN WCN-C. Advanced Practice Nurse / Adult Clinical Nurse Specialist
Diabetic Foot Ulcers Alex Khan APRN ACNS-BC MSN CWCN CFCN WCN-C Advanced Practice Nurse / Adult Clinical Nurse Specialist Organization of Wound Care Nurses www.woundcarenurses.org Objectives Identify Diabetic/Neuropathic
More informationCavus Foot: Subtle and Not-So-Subtle AOFAS Resident Review Course September 28, 2013
Cavus Foot: Subtle and Not-So-Subtle Course September 28, 2013 Matthew M. Roberts, MD Associate Professor of Clinical Orthopaedic Surgery Co-Chief, Foot and Ankle Service Hospital for Special Surgery Disclosure
More informationDiabetic Neuropathy. Nicholas J. Silvestri, M.D.
Diabetic Neuropathy Nicholas J. Silvestri, M.D. Types of Neuropathies Associated with Diabetes Mellitus p Chronic distal sensorimotor polyneuropathy p Focal compression neuropathies p Autonomic neuropathy
More informationMovement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types
Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness
More informationDifferential Diagnosis of Neuropathies and Compression. Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre
Differential Diagnosis of Neuropathies and Compression Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre Outline of talk Mononeuropathies median and anterior interosseous nerve ulnar nerve
More informationIndex. Note: Page numbers of article titles are in boldface type.
Neurol Clin N Am 20 (2002) 605 617 Index Note: Page numbers of article titles are in boldface type. A ALS. See Amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) active denervation
More informationPeripheral Neuropathies
Peripheral Neuropathies ELBA Y. GERENA MALDONADO, MD ACTING ASSISTANT PROFESSOR UNIVERSITY OF WASHINGTON MEDICAL CENTER Objectives Definition Neurophysiology Evaluation of polyneuropathies Cases Summary
More informationImaging findings of Lower Extremity Peripheral Nerves in Charcot-Marie Tooth
Original Research Imaging findings of Lower Extremity Peripheral Nerves in Charcot-Marie Tooth Jonelle M Petscavage-Thomas*, Sangeeta Chaudhary, Stephanie A Bernard, Eric A Walker and Gary A. Thomas Department
More informationAnesthesia recommendations for patients suffering from Welander distal myopathy
orphananesthesia Anesthesia recommendations for patients suffering from Welander distal myopathy Disease name: Welander distal myopathy ICD 10: G71.0 Synonyms: late adult onset type 1 distal myopathy;
More informationThe Diabetic Foot Latest Statistics
The Diabetic Foot Latest Statistics There are 2.6 million people with diagnosed diabetes in the UK. There are predicted to be 500,000 who have the condition but are unaware of it. There are 11,859 in TH
More informationIntroduction. Epidemiology Pathophysiology Classification Treatment
Diabetic Foot Introduction Epidemiology Pathophysiology Classification Treatment Epidemiology DM largest cause of neuropathy in N.A. 1 million DM patients in Canada Half don t know Foot ulcerations is
More informationSymptomatic pain treatments (carbamazepine and gabapentin) were tried and had only a transient and incomplete effect on the severe pain syndrome.
Laurencin 1 Appendix e-1 Supplementary Material: Clinical observations Patient 1 (48-year-old man) This patient, who was without a notable medical history, presented with thoracic pain and cough, which
More informationBalgrist Symposium zum Diabetischen Fuss. Der Charcot-Fuss Oktober diabetic neuropathies. symptoms. signs. sensory disorders.
symptoms sensory disorders spontaneous paraesthesia tingling burning by touch, pressure dysaesthesia sign pain continuous boring cutting drawing paroxysmal lancinating neuralgiform causalgic fluctuating,
More informationGenetics of Hereditary Spastic Paraplegia Dr. Arianna Tucci
Genetics of Hereditary Spastic Paraplegia 1 Clinical Research Fellow Institute of Neurology University College London Hereditary spastic paraplegia: definition Clinical designation for neurologic syndromes
More informationNEUROPATHY IN PERIPHERAL VASCULAR DISEASE 1
267 616.833-02:616.13-005 NEUROPATHY IN PERIPHERAL VASCULAR DISEASE 1 Its Bearing on Diabetic Neuropathy BY E. C. HUTCHINSON AND L. A. LIVERSKDGE (From the Department of Neurology, Manchester Royal Infirmary)
More informationDIABETIC NEUROPATHY ASSESSED AT TWO TIME POINTS FIVE YEARS APART
1 University Department of Neurology, Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina 2 Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina 3 Department of Hemodialysis, Sarajevo Clinical
More informationEvaluation of Peripheral Neuropathy. Evaluation of Peripheral Neuropathy - Introduction
Evaluation of Peripheral Neuropathy Chris Edwards, MD Ochsner Neurology, Main Campus Evaluation of Peripheral Neuropathy - Introduction A very common complaint in the clinic Presentation is variable Multiple
More informationPreventing Foot Ulcers in the Neuropathic Diabetic Foot. Glossary of Terms
Preventing Foot Ulcers in the Neuropathic Diabetic Foot Warren Woods, Certified Orthotist, Health Sciences Centre, Rehabilitation Engineering Department What you need to know Glossary of Terms Neuropathic
More informationCase Report Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
Case Reports in Neurological Medicine Volume 2013, Article ID 243652, 4 pages http://dx.doi.org/10.1155/2013/243652 Case Report Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
More informationTOXIC AND NUTRITIONAL DISORDER MODULE
TOXIC AND NUTRITIONAL DISORDER MODULE Objectives: For each of the following entities the student should be able to: 1. Describe the etiology/pathogenesis and/or pathophysiology, gross and microscopic morphology
More informationSlide 1. Slide 2. Slide 3. Intro to Physical Therapy for Neuromuscular Conditions. PT Evaluation. PT Evaluation
Slide 1 Intro to Physical Therapy for Neuromuscular Conditions PTA 103 Introduction to Clinical Practice 2 Slide 2 Mental status: consciousness, attention, orientation, cognition Communication: speech
More informationDeformity and Pain in Foot of Neuromuscular Disease
Deformity and Pain in Foot of Neuromuscular Disease CHA 의과학대학재활의학과김민영 (2012.11.10 제 4 회대한발의학회 ) Neuromuscular Diseases & Foot Deformity : almost Pain : infrequent Non-ambulatory, Ambulatory Neuromuscular
More informationin 3 non-ashkenazi Jewish families*
Journal of Medical Genetics, 1980, 17, 424-429 Autosomal recessive peripheral sensory neuropathy in 3 non-ashkenazi Jewish families* ISRAEL TAMARI, RICHARD M GOODMAN, IDA SAROVA, MARJORIE HERTZ, RAPHAEL
More informationAetiology Macroangiopathy occurs mainly distally ie Popliteal artery There is arterial wall calcification Microangiopathy is less common
DIABETIC FOOT Facts 5% of the population is diabetic 12% of diabetic admissions are with foot problems 1/3rd of diabetic foot ulcerations are neuropathic, 1/3rd are ischaemic and 1/3 are of a mixed in
More informationAWMA MODULE ACCREDITATION. Module Five: The High Risk Foot (Including the Diabetic Foot)
AWMA MODULE ACCREDITATION Module Five: The High Risk Foot (Including the Diabetic Foot) Introduction - The Australian Wound Management Association Education & Professional Development Sub Committee-(AWMA
More informationMOTOR NEURONE DISEASE
MOTOR NEURONE DISEASE Dr Arun Aggarwal Department of Rehabilitation Medicine, RPAH Department of Neurology, Concord Hospital. Motor Neurone Disease Umbrella term in UK and Australia (ALS in USA) Neurodegenerative
More informationHereditary distal spinal muscular atrophy
Journal of Neurology, Neurosurgery, and Psychiatry, 1980, 43, 413-418 Hereditary distal spinal muscular atrophy with vocal cord paralysis I D YOUNG AND P S HARPER From the Section ofmedical Genetics, Department
More informationLower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A
Lower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A Paolo Vinci a,b Mariano Serrao c,d Francesco Pierelli c Giorgio Sandrini e Valter Santilli f a Section of Rehabilitation
More informationDiagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline
J Neurol Neurosurg Psychiatry 2001;71:205 209 205 Department of Neurology, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands N R Rosenberg P Portegies M
More informationThe signs and symptoms of diabetic neuropathy vary, depending on the type of neuropathy and which nerves are affected.
DIABETIC NEUROPATHY Overview Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerve fibers throughout your body, but diabetic neuropathy
More informationAmerican Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights
American Board of Physical Medicine & Rehabilitation Part I Curriculum & Weights Neurologic Disorders 30% Stroke Spinal Cord Injury Traumatic Brain Injury Neuropathies a) Mononeuropathies b) Polyneuropathies
More informationA/Professor Arun Aggarwal Balmain Hospital
A/Professor Arun Aggarwal Balmain Hospital Nerve Conduction Studies Test to evaluate the function of motor / sensory nerves Evaluate Paraesthesia (numbness, tingling, burning) Weakness of arms and legs
More informationClinical Aspects of Peripheral Nerve and Muscle Disease. Roy Weller Clinical Neurosciences University of Southampton School of Medicine
Clinical Aspects of Peripheral Nerve and Muscle Disease Roy Weller Clinical Neurosciences University of Southampton School of Medicine Normal Nerves 1. Anterior Horn Cell 2. Dorsal root ganglion cell 3.
More informationDIAGNOSIS OF DIABETIC NEUROPATHY
DIAGNOSIS OF DIABETIC NEUROPATHY Dept of PM&R, College of Medicine, Korea University Dong Hwee Kim Electrodiagnosis ANS Clinical Measures QST DIAGRAM OF CASUAL PATHWAYS TO FOOT ULCERATION Rathur & Boulton.
More informationNeonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP
The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy
More informationAnatomy of the Spinal Cord
Spinal Cord Anatomy of the Spinal Cord Anatomy of the Spinal Cord Posterior spinal arteries Lateral corticospinal tract Dorsal column Spinothalamic tract Anterior spinal artery Anterior white commissure
More informationKeywords. Introduction. Use of 4-aminopyridine for Motor Weakness Due to Charcot- Marie - Tooth Hereditary Motor Sensory Neuropathy.
CASE REPORT Use of 4-aminopyridine for Motor Weakness Due to Charcot- Marie - Tooth Hereditary Motor Sensory Neuropathy Jay M. Meythaler* and Jean Peduzzi-Nelson* Department of Physical Medicine and Rehabilitation,
More informationPediatric Aspects of EDX
Pediatric Aspects of EDX Albert C. Clairmont, MD Associate Professor-Clinical The Ohio State University February 25, 2013 Objectives Overview of Pediatric Electrodiagnosis (EDX) Understand the different
More informationperipheral neuropathy peripheral neuropathy neuropathy peripheral neuropathy neuropathic foot heel Bilateral foot pain Bilateral heel pain bilateral
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health. The 2018 edition of ICD-10-CM G62.9. Auditory
More informationAdvances in genetic diagnosis of neurological disorders
Acta Neurol Scand 2014: 129 (Suppl. 198): 20 25 DOI: 10.1111/ane.12232 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Review Article Advances in genetic diagnosis
More informationComparison of diabetes patients with demyelinating diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
Comparison of diabetes patients with demyelinating diabetic sensorimotor polyneuropathy to those diagnosed with CIDP Samantha K. Dunnigan 1, Hamid Ebadi 1, Ari Breiner 1, Hans D. Katzberg 1, Leif E. Lovblom
More informationCharcot Arthropathy of the Foot & Ankle. MTAPA Annual Meeting June 2018 Emily Harnden, MD
Charcot Arthropathy of the Foot & Ankle MTAPA Annual Meeting June 2018 Emily Harnden, MD Background Disclosures None Learning Objectives Define the disease Recognize presenting signs/symptoms for proper
More informationHigh Risk Podiatry in a Vascular Setting; A new paradigm in Diabetic Foot Disease? Ereena Torpey Senior Podiatrist - FMC
High Risk Podiatry in a Vascular Setting; A new paradigm in Diabetic Foot Disease? Ereena Torpey Senior Podiatrist - FMC A new paradigm? Foot ulceration 101 Assessing Perfusion a new challenge Pressure
More informationElectrodiagnostic studies comprising of electromyography (EMG) and nerve
INTRODUCTION AND TERMINOLOGY Electrodiagnostic studies comprising of electromyography (EMG) and nerve conduction studies (NCS) are well-established objective methods for the diagnosis, quantification and
More informationDiabetes Mellitus and the Associated Complications
Understanding and the complications relating to the disease can assist the fitter to better serve patients. and the Associated Complications Released January, 2011 Total: 25.8 million people, or 8.3% of
More informationAccelerating Drug Discovery to Transform Patients Lives
Accelerating Drug Discovery to Transform Patients Lives CMT Overview and ACE-083 Phase II Trial Webinar April 3, 2017 Acceleron Forward-Looking Statements This presentation contains forward-looking statements
More informationThe Diabetic Foot Screen and Management Foundation Series of Modules for Primary Care
The Diabetic Foot Screen and Management Foundation Series of Modules for Primary Care Anita Murray - Senior Podiatrist Diabetes, SCH Learning Outcomes Knowledge of the Model of Care For The Diabetic Foot
More informationND Lesson 2.5 Jigsaw Case Study #1
ND Lesson 2.5 Jigsaw Case Study #1 Gabby Gabby is 5 years old. Her parents have consulted with many specialists throughout their daughter s life in hopes of finding an explanation for why their daughter
More informationFaculty Academic Appointments 7/2011-8/2016 Assistant Professor 7/2012-8/2016 Instructor Neurology Harvard Medical School
Vera Fridman, M.D. October 25, 2017 Office Address: Place of Birth: Neuromuscular Division Department of Neurology 12631 East 17 th Ave Mail Stop B185 Aurora, CO 80045 Phone: (303) 724-2188 Fax: (303)
More informationOur senses provide us with wonderful capabilities. If you had to lose one, which would it be?
Our senses provide us with wonderful capabilities. If you had to lose one, which would it be? Neurological disorders take away sensation without a choice! http://neuroscience.uth.tmc.edu/s2/chapter04.html
More informationElectrodiagnostics for Back & Neck Pain. Steven Andersen, MD Providence Physiatry Clinic
Electrodiagnostics for Back & Neck Pain Steven Andersen, MD Providence Physiatry Clinic Electrodiagnostics Electromyography (EMG) Needle EMG exam (NEE) Nerve conduction studies (NCS) Motor Sensory Late
More informationKim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism
Kim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism st1 Classification and definition of diabetic neuropathies Painful diabetic peripheral neuropathy Diabetic autonomic neuropathy
More informationIntroduction and aims of the study
Introduction and aims of the study 1 Chapter 1 Motor neuron diseases include the most incapacitating and life-threatening illnesses but also rather benign disorders with only mild symptoms and slow progression.
More informationLecture VIII. The Spinal Cord, Reflexes and Brain Pathways!
Reflexes and Brain Bio 3411! Monday!! 1! Readings! NEUROSCIENCE 5 th ed: Review Chapter 1 pp. 11-21;!!Read Chapter 9 pp. 189-194, 198! THE BRAIN ATLAS 3 rd ed:! Read pp. 4-17 on class web site! Look at
More informationCritical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski
Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM Andrzej Sladkowski Potential causes of weakness in the ICU-1 Muscle disease Critical illness myopathy Inflammatory myopathy Hypokalemic
More informationPainful Diabetic Neuropathy Effective Management. Ketan Dhatariya Consultant in Diabetes NNUH
Painful Diabetic Neuropathy Effective Management Ketan Dhatariya Consultant in Diabetes NNUH Neuropathic Pain Prevalence varies between 10 and 90% depending on classification Accounts for 50-75% of non-traumatic
More informationCase 3. Your Diagnosis?
Case 3 45 year-old presenting with a history of injury to the right shoulder whilst working in the freezing work. He was loading a sheep over an incline with his arm around the sheep. He felt pain in the
More informationAbnormal EMG Patterns in Disease. Amanda C. Peltier, MD MS October 12, 2013
Abnormal EMG Patterns in Disease Amanda C. Peltier, MD MS October 12, 2013 Disclosures I have no financial relationships to disclose that are relative to the content of my presentation. Basic Tenets of
More informationPodiatry in Practice. Alan M. Singer, DPM, FACFAS
Podiatry in Practice Alan M. Singer, DPM, FACFAS Podiatry in Practice Alan Singer, D.P.M. UNIVERSITY PODIATRY GROUP Onychomycosis Anti-fungals Onychocryptosis (Ingrown Nails) Ingrown Nails Partial Nail
More informationMUSCULOSKELETAL AND NEUROLOGICAL DISORDERS
MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS There are a wide variety of Neurologic and Musculoskeletal disorders which can impact driving safety. Impairment may be the result of altered muscular, skeletal,
More informationComparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome
Iranian Journal of Neurology Original Paper Iran J Neurol 2014; 13(3): 138-143 Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome Received: 9 Mar 2014 Accepted:
More informationSingle Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions
Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are
More informationVASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS
VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE
More informationDepartment of Neurology/Division of Anatomical Sciences
Spinal Cord I Lecture Outline and Objectives CNS/Head and Neck Sequence TOPIC: FACULTY: THE SPINAL CORD AND SPINAL NERVES, Part I Department of Neurology/Division of Anatomical Sciences LECTURE: Monday,
More informationYear 2 MBChB Clinical Skills Session Examination of the Motor System
Year 2 MBChB Clinical Skills Session Examination of the Motor System Reviewed & ratified by: o o o o Dr D Smith Consultant Neurologist Dr R Davies Consultant Neurologist Dr B Michael Neurology Clinical
More informationSENSORY (ASCENDING) SPINAL TRACTS
SENSORY (ASCENDING) SPINAL TRACTS Dr. Jamila El-Medany Dr. Essam Eldin Salama OBJECTIVES By the end of the lecture, the student will be able to: Define the meaning of a tract. Distinguish between the different
More informationJMSCR Vol 04 Issue 12 Page December 2016
JMSCR Vol 04 Issue 12 Page 14551-14556 December 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.42
More informationNadeem Ali, MBBS; Sudesh Sharma, MS; Sonali Sharma, MBBS; Younis Kamal, MS, and Sushil Sharma, MS
Case Report Iran J Pediatr Dec 2012; Vol 22 (No 4), Pp: 559-563 Congenital Insensitivity to Pain with Anhidrosis (HSAN Type IV), Extremely Rare Syndrome that Can Be Easily Missed by Bone and Joint Surgeons:
More informationSigns of neuropathy in the lower legs and feet of patients with acute intermittent porphyria
Journal of Internal Medicine 2000; 248: 27±32 Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria A. WIKBERG 1,C.ANDERSSON 2 &F.LITHNER 3 From the 1 Department
More informationAFL NSW/ACT Exemption & Dispensation Policy
AFL NSW/ACT Exemption & Dispensation Policy Last reviewed 14 May 2012. AFL NSW/ACT s policy is that age exceptions and/or dispensations will only exist in cases of disability These exemptions require approval
More informationNERVOUS SYSTEM. Academic Resource Center. Forskellen mellem oscillator og krystal
NERVOUS SYSTEM Academic Resource Center Forskellen mellem oscillator og krystal Overview of the Nervous System Peripheral nervous system-pns cranial nerves spinal nerves ganglia peripheral nerves enteric
More information